We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byIan Madden
Modified over 3 years ago
© 2005, Genentech PAT Applications for Biochemical Processes Shih-Hsie Pan Interphex, March 19, 2009
© 2005, Genentech PAT Framework Process Monitoring Process Analysis Process Control Process Design Multivariate data acquisition and analysis tools Process chemometrics Intelligent use of process data Modern process analyzers Process analytical chemistry tools In-process monitoring techniques Process and endpoint monitoring and control tools Process supervisory control High level multivariate control strategies Design for Quality Continuous improvement and knowledge management tools FMECA DOE Slide 2
© 2005, Genentech PAT: Process Information Enabling QbD Laboratory Off-LineOn-LineIn-LineAt-Line Production Area Diverted Sample Inserted Probe Non Invasive No Product Contact Real-timerelease Predictive Modeling NIR Probe Transition Analysis Slide 3
© 2005, Genentech Benefits of PAT for Biologics Increase knowledge of product and process –Identify critical steps and parameters (CCPs and CPPs) that impact quality –Lower the cost of process improvement to increase yield, quality & robustness –Minimize process validation cost – direct, real-time process control –Facilitate reduction of batch-to-batch variability for better quality and predictability Allow near real time critical parameter conformance monitoring and comparisons – continuous quality assurance and validation –Assist validation efforts for characterization and documentation of process changes Reduce testing requirements at end of process Assess deviation impact in real time –Avoid costs of processing unreleasable batches –Data justification of batch release Provide an ability to quickly identify shifts, trends, or outliers in the data, so that investigations can be conducted and decisions made on lot release quickly to reduce manufacturing risk. Slide 4
© 2005, Genentech Automated (At-Line) Cell Count and Viability Determination By Image Analysis Significant Reduction in RSD Improved Consistency in Mfg Operations based on Cell Count or %Viability Courtesy of Polina Rapoport Slide 5
© 2005, Genentech Real time method developed for monitoring column packing quality. Calculates plate number directly from transition curve. No off-line pulse injection tests required; uses process data. Predictive of column performance. Chromatographic Transition Analysis Slide 6
© 2005, Genentech Affinity Elution Chromatogram Chromatogram improved after lowering flow adapter Loss of Column Integrity Slide 7
© 2005, Genentech HETP data clearly identifies changes in column integrity. Values increase with time after column packing. Original HETP value is restored after lowering the top flow adapter. Increased measurement variability is observed when column integrity decreases. Column Repacked Lowered Flow Adapter Transition Analysis Identifies Changes Slide 8
© 2005, Genentech Packed Cell Volume PCV is an accurate measurement of biomass, but it also lends itself to many inconsistencies… 1) Manual operation that is variable from operator to operator. 2) Measurement is performed visually which can also be very subjective. Drivers to evaluate alternative methods of determining biomass to ensure a more robust and informative estimate of inoculum transfer time. Slide 9
© 2005, Genentech Oxygen Transfer Rate (OTR) -Definition -k L a = mass transfer coefficient,based on empirical data from each bioreactor family -C* = dissolved oxygen level at oxygen saturation point -C L = Dissolved Oxygen Concentration (should be a constant) -Pros- -OTR directly measures cell growth -OTR is a non-invasive method, per guidance definition Slide 10
© 2005, Genentech Case Study Results R 2 Value vs. Current (Off-Line) Method On-Line Method Non- Invasive Method N-3 Stage N-2 Stage N-1 Stage Using Technology…. To manage process performance Slide 11
© 2005, Genentech Prediction of protein titers with PLS model based on 1695 variables Data courtesy of Kirin Jamison Slide 12
© 2005, Genentech My colleagues at Genentech: Eric Fallon Robert Kiss Harry Lam Acknowledgement
© 2005, Genentech Back-up Slide 14
© 2005, Genentech Additional At-Line Analyses Have Increased Measurable Parameters Blood gas analyzers –Enable measurement of glucose, lactate, pCO2, pH, pO2, ammonium, sodium, potassium and other metabolites Amino acid analysis by on-line HPLC –Amino acids along with glucose can be measured every hour with automated HPLC –Can enable more comprehensive view of how metabolism shifts over the course of a culture –Can also be used for medium development & optimization Automated image analysis for cell count, viability, cell size (example) Slide 15
© 2005, Genentech QbD Model Slide 16
Xcellerex … speeding medicines to people … PAT for Biologics Ensuring Quality of Biologically Produced Drugs FDA Advisory Committee on Pharmaceutical Sciences.
From Design of Experiments to closed loop control Petter Mörée & Erik Johansson Umetrics.
Quality by Design (QbD) Myth : An expensive development tool ! Fact : A tool that makes product development and commercial scale manufacturing simple !
Siemens Nederland N.V FDA13April Presented by Troy Logan at the Advisory Committee for Pharmaceutical Science meeting on April 13, 2004.
| Jade (with her mother) Fabry disease USA UPSTREAM DEVELOPMENT OF HIGH CELL DENSITY, PERFUSION PROCESSES FOR CONTINUOUS MANUFACTURING.
EQUIPMENT and METHOD VALIDATION. “Methods validation is the process of demonstrating that analytical procedures are suitable for their intended use”
Bacterial Growth l Introduction –Population vs. Cellular Growth –Exponential vs. Arithmetic Growth –Bacterial Growth - Binary Fission.
Product & Process Working Group February 26, 2002.
Figure 3: Process fingerprint monitoring of a bio- reactor Biopharm production methods need effective real-time monitoring and control to guarantee a low-cost,
1 PAT and Biological Products Tom Layloff FDA-SGE Management Sciences for Health The views expressed here are those of the author and not necessarily.
Role of Statistics in Pharmaceutical Development Using Quality-by-Design Approach – an FDA Perspective Chi-wan Chen, Ph.D. Christine Moore, Ph.D. Office.
CHROMATOGRAPHY Chromatography basically involves the separation of mixtures due to differences in the distribution coefficient (equilibrium.
Managing Quality within a Network of Suppliers Eda Ross Montgomery Melody Hebert April 6, 2011.
Engineering of Biological Processes Lecture 4: Production kinetics Mark Riley, Associate Professor Department of Ag and Biosystems Engineering The University.
Sensitivity Analysis for the Purposes of Parameter Identification of a S. cerevisiae Fed-batch Cultivation Sensitivity Analysis for the Purposes of Parameter.
1 Alberto Montanari University of Bologna Basic Principles of Water Resources Management.
1 DOE-based Automatic Process Control with Consideration of Model Uncertainties Jan Shi and Jing Zhong The University of Michigan C. F. Jeff Wu Georgia.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
High-throughput screening of HIC media in PreDictor™ plates for capturing a recombinant protein from E.coli Charlotte Brink, Carina Engstrand, Eva Heldin.
Instrumental Analysis (I) HPLC Tutorial 8. Graded presentation Students in groups of 4-5 individuals are asked to prepare a presentation (weight=5% of.
Reactors . ä Reactor: a “container” where a reaction occurs ä Examples: ä Clear well at water treatment plant (chlorine contact) ä Activated sludge tank.
Slide 1 Insert your own content. Slide 2 Insert your own content.
Annex I: Methods & Tools prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY.
Integration of PI client tools in support of large-scale cell culture manufacturing Oliver Yu 14-May-2003.
Validation | Slide 1 of 27 August 2006 Validation Good Manufacturing Practice (GLP) WHO Technical Report Series, No. 937, Annex 4.
Cell Growth Kinetics -Introduction -Growth patterns and kinetics in batch culture - growth phases - effect of factors: oxygen supply - heat generation.
PAT Validation Working Group Process and Analytical Validation Working Group Arthur H. Kibbe, Ph.D. Chair June 13, 2002.
PROCESS ANALYTICAL TECHNOLOGY – A REVIEW By Mr. Akash Mali DEPARTMENT OF PHARMACEUTICS, G.I.P.E.R., LIMB, SATARA. 1.
Introduction to Chromatography Definition Chromatography is a separation technique based on the different interactions of compounds with two phases, a.
Learnings from Pre-approval Joint Inspection of a GSK QbD Product with US-FDA & EMA and the application of Continuous Verification 17 May 2011, Beijing,
Laboratory Perspective on Testing Methodologies Wendy Warren-Serna, Ph.D. USDA-FSIS Public Meeting Control of E. coli O157:H7.
1 FDA Regulatory Perspective on Continuous Manufacturing Celia N. Cruz, Ph.D. Acting Branch Chief CDER/OPQ/OPF/DPAII IFPAC Summer Summit, Carolina, PR.
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Strengthening Your HR Capacity The Government of Canada Perspective Margaret Van Amelsvoort-Thoms Executive Director, Office of the Chief HR Officer Government.
Process Analytical Technologies Subcommittee Product and Process Development: An Industry Perspective David Rudd PhD Process Technology GlaxoSmithKline.
Introduction and Project Definition Russell L. Jones January 26, 2005.
Coupling Process Control Systems and Process Analytics Robert Wojewodka –Technology Manager Philippe Moro –IS Manager Terry Blevins – Principal Technologist.
Guilin, January, 9 – 13, 2006 Dr. Birgit Schmauser, BfArM, Bonn Verification of applicability of the validated/compendial API analytical method for the.
History of Chromatography n Early LC carried out in glass columns n diameters: 1-5 cm n lengths: cm n Size of solid stationary phase n diameters:
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
Late Phase Solubility: an Advanced Automated Workflow to Support Crystallization Development Jun Qiu and Benjamin Cohen Late Phase Chemical Development.
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Providing comprehensive scientific resources to environmental clients worldwide. Dissolved Gas Analysis: A Review and Comparison.
Kraft Pulping Modeling & Control 1 Control of Batch Kraft Digesters.
Objectives Uncertainty analysis Quality control Regression analysis.
Large Molecule Technologies Cell Culture/Fermentation Metabolite feedback control In-Line Nova/NovaFlex/BGA FTIR/NIR/Raman Capacitance (cell mass)
CELL-tainer® Single use Bioreactor November 2013 CellD 20bis, rue du Chapitre F ROQUEMAURE Tel : +33 (0) Fax : +33 (0)
Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection: Viral antigens;
Microfluidics Technology Fair, October 3, 2006 Parallel Integrated Bioreactor Arrays for Bioprocess Development Harry Lee, Paolo Boccazzi, Rajeev Ram,
GAS TRANSPORT Lecture – 6 Dr. Zahoor Ali Shaikh 1.
© 2017 SlidePlayer.com Inc. All rights reserved.